Technical Advantages
- The cosmetic ingredient is a cell culture–derived bioactive component and has been assigned an INCI name
- Developed based on a patented umbilical cord–derived cell culture technology, ensuring consistency and traceability
- The ingredient has been evaluated through application-focused studies, with results planned for publication in an international journal
- Manufactured using a high-purity and high-quality production process, ensuring stable composition and performance
- Fully automated, GTP-compliant manufacturing system ensures consistent quality and scalable production capacity
- Production equipment has obtained TFDA Class II Innovative Medical Device certification, representing an industry-leading standard in Taiwan
Market Deployment Strategy
- Phased market expansion: Initial focus on the Taiwanese market, followed by expansion across the Asia-Pacific region. Strategic partnerships will be established with leading biotechnology companies to support international growth, with long-term entry into North American and European markets.
- Global deployment plan: Establish subsidiaries in the United States, Europe, and Asia, and collaborate with international research and development teams to continuously advance technology platforms and application capabilities.
- Brand positioning and influence: We aim to become a globally recognized leader in advanced bioactive ingredient technologies, strengthening product competitiveness and expanding international market presence.
